Neumora Reports KOASTAL-1 Study Data on Navacaprant for Depression
January 4, 2025
Neumora Therapeutics, a clinical-stage biopharmaceutical company with a therapeutics pipeline consisting of seven clinical and pre-clinical brain disease programs, announced results from the Phase 3